Lori Anne Kunkel - 02 Jan 2025 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORIC	Stock Option (right to buy)	Award	$0	+35,000		$0.000000	35,000	02 Jan 2025	Common Stock	35,000	$8.26	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2025.